Mark A. Gardner - 29 Jun 2026 Form 4 Insider Report for GeneDx Holdings Corp. (WGS)

Reporting relationship: President
Issuer ticker: WGS
Reported as of: 29 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 16:10:46 UTC
Prior SEC filing: 16 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Bridget Brown, Attorney-in-Fact

Key filing fact

Mark A. Gardner filed Form 4 for GeneDx Holdings Corp. (WGS) on 01 Jul 2026.

Key facts

This page summarizes Mark A. Gardner's Form 4 filing for GeneDx Holdings Corp. (WGS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2026, 16:10.

Change

Previous filing in this sequence was filed on 16 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001955242 Primary reporting owner

GARDNER MARK A

Relationship: President
Address: C/O GENEDX HOLDINGS CORP., 333 LUDLOW ST., NORTH TOWER, 6TH FLOOR, STAMFORD
Signature: /s/ Bridget Brown, Attorney-in-Fact
Signature date: 01 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

WGS transaction Derivative

Restricted Stock Unit

Award

Transaction value
Shares: +35,441
Change %
Price: $0.000000^*
Shares after: 35,441
Date: 29 Jun 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 35,441
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.

Footnote F2

The award shall vest as to 25% of the total award annually each July 1, with the first tranche vesting on July 1, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. These restricted stock units do not have an expiration date; they either vest or are cancelled prior to the vesting date.